Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02783664 · ClinicalTrials.gov registry record

Evaluating the Effects of Genetic Testing on Patients' Stress Levels

A clinical trial of Breast Cancer, sponsored by Medical College of Wisconsin.

Active
Registry status
164
Enrollment target
1
Study location

NCT02783664: Active study of Breast Cancer, sponsored by Medical College of Wisconsin.

NCT02783664 is a study of Breast Cancer that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 164 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02783664, a study of Breast Cancer, is active but no longer recruiting, sponsored by Medical College of Wisconsin.

ACTIVE NOT RECRUITING
Registry status
164 participants
Enrollment target
1
Study location

Study Summary

This prospective Medical College of Wisconsin Cancer Center study will evaluate stress levels in breast cancer patients undergoing genetic testing. It aims to establish baseline stress levels, evaluate pre- and post-test stress levels at multiple time points, focus on the changes in stress levels for the different resulting subgroups. This will help the clinical staff to provide better care for patients both medically and psychologically through potential interventions to decrease stress.

Primary Outcome

The STAI assesses current and trait anxiety symptoms. The investigators use the STAI to measure anxiety at baseline.

Conditions Studied

Interventions

  • OTHER Questionnaires to Evaluate Anxiety Related to Genetic Testing

Study Locations (1)

Wisconsin

  • Froedtert Hospital - Milwaukee

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2016-07
Est. Completion 2027-07
Medical College of Wisconsin

447 total trials

What the registry record for NCT02783664 still lists

NCT02783664 is an observational study that tracks outcomes without assigning an intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires to Evaluate Anxiety Related to Genetic Testing is the first listed.

NCT02783664 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT02783664 about?

NCT02783664 is a clinical study titled "Evaluating the Effects of Genetic Testing on Patients' Stress Levels". This prospective Medical College of Wisconsin Cancer Center study will evaluate stress levels in breast cancer patients undergoing genetic testing. It aims to establish baseline stress levels, evaluate pre- and post-test stress levels at multiple time points, focus on the changes in stress levels fo...

What is the current status of trial NCT02783664?

This trial is currently active not recruiting. The enrollment target is 164 participants. The study started on 2016-07. Estimated completion is 2027-07.

What conditions does trial NCT02783664 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02783664?

The interventions under investigation include: Questionnaires to Evaluate Anxiety Related to Genetic Testing (OTHER).

Who is sponsoring clinical trial NCT02783664?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02783664 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02783664's enrollment target sits among peer trials

164 429th of 1224 higher than 794 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04891289 · 164 participants · Phase 2

    Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

  • NCT04893226 · 164 participants · NA

    Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women

  • NCT05270213 · 164 participants · Phase 1

    Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

  • NCT05543681 · 164 participants · Phase 2

    Clinical Trial on Agitation in Alzheimer's Dementia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02783664, the US trial registry maintained by the National Library of Medicine. NCT02783664 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.